A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

BACKGROUND & AIMS: Elimination of chronic HBV/HDV infection remains a major global health challenge. Targeting excessive hepatitis B surface antigen (HBsAg) release may provide an interesting window of opportunity to break immune tolerance and to achieve a functional cure using additional antivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Burm, Rani, Van Houtte, Freya, Verhoye, Lieven, Mesalam, Ahmed Atef, Ciesek, Sandra, Roingeard, Philippe, Wedemeyer, Heiner, Leroux-Roels, Geert, Meuleman, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898450/
https://www.ncbi.nlm.nih.gov/pubmed/36748051
http://dx.doi.org/10.1016/j.jhepr.2022.100646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898450/
https://www.ncbi.nlm.nih.gov/pubmed/36748051
http://dx.doi.org/10.1016/j.jhepr.2022.100646

Ejemplares similares